Bcl-10 (N-Terminus) antibody

B-cell lymphoma/leukemia 10
B-cell CLL/lymphoma 10, Bcl-10
CARD-containing molecule enhancing NF-kappa-B
CARD-like apoptotic protein, hCLAP
CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER
Cellular homolog of vCARMEN, cCARMEN
Cellular-E10, c-E10
Mammalian CARD-containing adapter molecule E10, mE10
Gene name: BCL10, CARMEN, CIPER, CLAP, IMD37
As low as $738.10
In stock
Overexpression of Bcl10 induces JNK, p38, and NF- B activation. Bcl10 interacts with caspase- 9, enhances pro-caspase-9 processing, and induces apoptosis through caspase-9 activation. Bcl10 exhibits a variety of mutations in MALT lymphoma and in B and T cell lymphomas indicating that it may be commonly involved in the pathogenesis of human tumors. Bcl10 is expressed in many human and murine tissues and cell lines.
More Information
ID Covalab pab60043
Product type Primary antibodies
Clonality Polyclonal antibody
Raised in Rabbit
Immunogen Synthetic peptide corresponding to aa 5-19 (N-terminus ) of human Bcl-10
Activity cross reaction Reacts with human Bcl-10.
Species Hu
Labelling None
Form Purified
Preservative NaN3 0.02%
Storage instructions Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
Target Bcl-10
Uniprot ID O95999
Gene ID 8915
Applications ICC, IF, IHC - P, WB
Working dilutions Optimal dilution should be determined by the end user.
The following are guidelines only:
IHC-P (10 µg/ml)
WB (1 µg/ml)
ICC (1 µg/ml)
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account